Activation of PPARγ/p53 signaling is required for curcumin to induce hepatic stellate cell senescence

Cell Death and Disease

Volumn 7, Issue 4, 2016, Pages

  Jin, H ^a   Lian, N ^a   Zhang, F ^a   Chen, L ^a   Chen, Q ^a   Lu, C ^a   Bian, M ^a   Shao, J ^a   Wu, L ^a   Zheng, S ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ALPHA1 PROCOLLAGEN; BETA GALACTOSIDASE; BIOLOGICAL MARKER; CURCUMIN; ETOPOSIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P16; PROTEIN P21; PROTEIN P53; TELOMERASE; UNCLASSIFIED DRUG; BENZOTHIAZOLE DERIVATIVE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 2A; ENZYME INHIBITOR; HIGH MOBILITY GROUP A1A PROTEIN; PIFITHRIN; TOLUENE;

ANIMAL CELL; ARTICLE; CELL AGING; ENZYME ACTIVATION; HEPATIC STELLATE CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; LIVER FIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; CHEMICALLY INDUCED; CYTOLOGY; DRUG EFFECTS; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; LIVER; LIVER CIRRHOSIS; MALE; METABOLISM; MOUSE; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; BENZOTHIAZOLES; CELL AGING; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CURCUMIN; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ENZYME INHIBITORS; HEPATIC STELLATE CELLS; HMGA1A PROTEIN; LIVER; LIVER CIRRHOSIS; MALE; MICE; MICE, INBRED ICR; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TOLUENE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84992199210     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2016.92     Document Type: Article

References (37)

1. Kisseleva T, Brenner DA. Hepatic stellate cells and the reversal of fibrosis. J Gastroenterol Hepatol 2006; 21(Suppl 3): S84–S87.
2. Kisseleva T, Brenner DA. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J Gastroenterol Hepatol 2007; 22(Suppl 1): S73–S78.
3. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134: 1655–1669.
4. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008; 88: 125–172.
5. Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C et al. Senescence of activated stellate cells limits liver fibrosis. Cell 2008; 134: 657–667.
6. Schnabl B, Purbeck CA, Choi YH, Hagedorn CH, Brenner D. Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype. Hepatology 2003; 37: 653–664.
7. Kuilman T, Michaloglou C, Mooi WJ, Peeper DS. The essence of senescence. Genes Dev 2010; 24: 2463–2479.
8. von Figura G, Hartmann D, Song Z, Rudolph KL. Role of telomere dysfunction in aging and its detection by biomarkers. J Mol Med (Berl) 2009; 87: 1165–1171.
9. Karlseder J, Smogorzewska A, de Lange T. Senescence induced by altered telomere state, not telomere loss. Science 2002; 295: 2446–2449.
10. Kim WY, Sharpless NE. The regulation of INK4/ARF in cancer and aging. Cell 2006; 127: 265–275.
11. Wang C, Jurk D, Maddick M, Nelson G, Martin-Ruiz C, von Zglinicki T. DNA damage response and cellular senescence in tissues of aging mice. Aging Cell 2009; 8: 311–323.
12. Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 2002; 415: 45–53.
13. Adamovich Y, Adler J, Meltser V, Reuven N, Shaul Y. AMPK couples p73 with p53 in cell fate decision. Cell Death Differ 2014; 21: 1451–1459.
14. Marra F, Efsen E, Romanelli RG, Caligiuri A, Pastacaldi S, Batignani G et al. Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 2000; 119: 466–478.
15. Zheng S, Chen A. Activation of PPARgamma is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro. Biochem J 2004; 384: 149–157.
16. Park JK, Ki MR, Lee HR, Hong IH, Ji AR, Ishigami A et al. Vitamin C deficiency attenuates liver fibrosis by way of up-regulated peroxisome proliferator-activated receptor-gamma expression in senescence marker protein 30 knockout mice. Hepatology 2010; 51: 1766–1777.
17. Xu J, Fu Y, Chen A. Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am J Physiol Gastrointest Liver Physiol 2003; 285: G20–G30.
18. Zhou Y, Zheng S, Lin J, Zhang QJ, Chen A. The interruption of the PDGF and EGF signaling pathways by curcumin stimulates gene expression of PPARgamma in rat activated hepatic stellate cell in vitro. Lab Invest 2007; 87: 488–498.
19. Fu Y, Zheng S, Lin J, Ryerse J, Chen A. Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol 2008; 73: 399–409.
20. Zhang F, Zhang Z, Chen L, Kong D, Zhang X, Lu C et al. Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells. J Cell Mol Med 2014; 18: 1392–1406.
21. Zhang Z, Guo Y, Zhang S, Zhang Y, Wang Y, Ni W et al. Curcumin modulates cannabinoid receptors in liver fibrosis in vivo and inhibits extracellular matrix expression in hepatic stellate cells by suppressing cannabinoid receptor type-1 in vitro. Eur J Pharmacol 2013; 721: 133–140.
22. Narita M, Krizhanovsky V, Nunez S, Chicas A, Hearn SA, Myers MP et al. A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 2006; 126: 503–514.
23. Storer M, Mas A, Robert-Moreno A, Pecoraro M, Ortells MC, Di Giacomo V et al. Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 2013; 155: 1119–1130.
24. d'Adda di Fagagna F. Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer 2008; 8: 512–522.
25. Li T, Kon N, Jiang L, Tan M, Ludwig T, Zhao Y et al. Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell 2012; 149: 1269–1283.
26. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965; 37: 614–636.
27. Schrader J, Fallowfield J, Iredale JP. Senescence of activated stellate cells: not just early retirement. Hepatology 2009; 49: 1045–1047.
28. Sasaki M, Nakanuma Y. Cellular senescence in biliary pathology. Special emphasis on expression of a polycomb group protein EZH2 and a senescent marker p16INK4a in bile ductular tumors and lesions. Histol Histopathol 2015; 30: 267–275.
29. Serrano M. Cancer: a lower bar for senescence. Nature 2010; 464: 363–364.
30. Bitto A, Crowe EP, Lerner C, Torres C, Sell C. The senescence arrest program and the cell cycle. Methods Mol Biol 2014; 1170: 145–154.
31. Foster DA, Yellen P, Xu L, Saqcena M. Regulation of G1 cell cycle progression: distinguishing the restriction point from a nutrient-sensing cell growth checkpoint(s). Genes Cancer 2010; 1: 1124–1131.
32. Jacobs JJ. Senescence: back to telomeres. Nat Rev Mol Cell Biol 2013; 14: 196.
33. Vigneron A, Vousden KH. p53, ROS and senescence in the control of aging. Aging (Albany NY) 2010; 2: 471–474.
34. Kong X, Feng D, Wang H, Hong F, Bertola A, Wang FS et al. Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice. Hepatology 2012; 56: 1150–1159.
35. Zhang F, Ni C, Kong D, Zhang X, Zhu X, Chen L et al. Ligustrazine attenuates oxidative stress-induced activation of hepatic stellate cells by interrupting platelet-derived growth factor-beta receptor-mediated ERK and p38 pathways. Toxicol Appl Pharmacol 2012; 265: 51–60.
36. Schmittgen TD, Zakrajsek BA, Mills AG, Gorn V, Singer MJ, Reed MW. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem 2000; 285: 194–204.
37. Singh V, Biswas RK, Singh BN. Double recombinant Mycobacterium bovis BCG strain for screening of primary and rationale-based antimycobacterial compounds. Antimicrob Agents Chemother 2014; 58: 1389–1396.